WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Sunshine Biopharma earnings were -$5.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SBFM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.6M, up 25.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SBFM reported annual earnings of -$6.0M, with 16.4% growth.

SBFM earnings history

Current Revenue
$35.3M
Current Earnings
-$5.8M
Current Profit Margin
-16.5%

SBFM Return on Equity

Current Company
-24.2%
Current Industry
1.8%
Current Market
33%
SBFM's Return on Equity (-24.2%)... subscribe to Premium to read more.
High Return on Equity Performance

SBFM Return on Assets

Current Company
-18.9%
Current Industry
3.9%
SBFM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SBFM announces earnings.

SBFM Return on Capital Employed

Current Company
-19.85%
Current Industry
9.6%
SBFM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SBFM vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SBFM-$5.21M-$5.83MN/A-$10.15
APUS-$53.82M-$58.17MN/A-$36.57
YCBD-$1.18M-$3.08MN/A$0.24
AKAN-$46.14M-$45.65MN/A-$662.22
SNOA-$2.37M-$2.26MN/A-$1.22
View Top Pharmaceutical Stocks

Sunshine Biopharma Earnings Reports & History FAQ

What were Sunshine Biopharma's earnings last quarter?

On SBFM's earnings call on Aug 11, 2026, Sunshine Biopharma (NASDAQ: SBFM) reported Q2 2026 earnings per share (EPS) of -$1.15, up 70.81% year over year. Total SBFM earnings for the quarter were -$1.56 million. In the same quarter last year, Sunshine Biopharma's earnings per share (EPS) was -$3.94.

If you're new to stock investing, here's how to buy Sunshine Biopharma stock.

Is Sunshine Biopharma profitable or losing money?

As of the last Sunshine Biopharma earnings report, Sunshine Biopharma is currently losing money. Sunshine Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$5.83 million, a 7.52% decrease year over year.

What was SBFM's earnings growth in the past year?

As of Sunshine Biopharma's earnings date in Aug 11, 2026, Sunshine Biopharma's earnings has grown year over year. SBFM earnings in the past year totalled -$5.83 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.